Volz, Martin
Schaumburger, Jens
Gellißen, Jörg
Grifka, Joachim
Anders, Sven http://orcid.org/0000-0002-7202-0778
Clinical trials referenced in this document:
Documents that mention this clinical trial
A randomized controlled trial demonstrating sustained benefit of autologous matrix-induced chondrogenesis (AMIC®) over microfracture: 10-year follow-up
https://doi.org/10.1007/s00590-024-03948-0
Funding for this research was provided by:
Geistlich Pharma
Universität Regensburg
Article History
Received: 9 January 2024
Accepted: 2 April 2024
First Online: 17 April 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The study was approved by the Ethics Committee (03–088, 03/173-MZ and 20–1875-101, ZKS, University of Regensburg, Germany), conducted according to the Declaration of Helsinki and Good Clinical Practice and registered on clinicaltrials.gov (NCT02993510).
: Informed consent was given by every patient participating in this study.
: The authors affirm that human research participants provided informed consent for publication of the images in Fig. InternalRef removed.